Загрузка...
Use of hemodialysis for the treatment of intracerebral hemorrhage in patients on dabigatran with normal renal function
Dabigatran is a direct thrombin inhibitor which is approved by the Food and Drug Administration (FDA) for prevention of embolic stroke in patients with atrial fibrillation. Dabigatran has been shown to be non- inferior to warfarin in preventing stroke in patients with atrial fibrillation [1, 6]. The...
Сохранить в:
| Опубликовано в: : | Clin Nephrol Case Stud |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dustri-Verlag Dr. Karl Feistle
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5437993/ https://ncbi.nlm.nih.gov/pubmed/29043124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CNCS108253 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|